Correspondence to Dr Anne Eskild, Institute of Clinical Medicine, Univeristy of 0316 Oslo, Norway; anne.eskild{at}medisin.uio.no The authors used the Medical Birth Registry of Norway for their study.
Drug treatment to reduce cholesterol to new target levels is now recommended in four moderate- to high-risk patient populations: patients who have already sustained a cardiovascular event, adult ...
This electronic resource aims to provide physicians with fast and easy access to practical guidelines linked to the best available research evidence. It covers a wide range of medical conditions and ...
Correspondence to Dr Feng Xie, Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Canada; fengxie{at}mcmaster.ca; Dr Pablo Alonso-Coello, Iberoamerican Cochran ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
Correspondence to Dr Elaine Lehane, Catherine McAuley School of Nursing and Midwifery, University College Cork, Cork T12 K8AF, Ireland; e.lehane{at}ucc.ie To highlight and advance clinical ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
Correspondence to Dr Zachary Munn, JBI, The University of Adelaide Faculty of Health and Medical Sciences, Adelaide, South Australia, Australia; zachary.munn{at}adelaide.edu.au We are concerned about ...
Correspondence to Dr Mark H Ebell, Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, 125 Miller Hall, UGA Health Sciences Campus, Athens, GA 30602, USA; ...
Correspondence to Dr Mohammad Hassan Murad, Evidence-based Practice Center, Mayo Clinic, Rochester, MN 55905, USA; murad.mohammad{at}mayo.edu When decision makers make a recommendation based on ...
Objective To determine, for people seeking a date online, what activities and behaviours have an effect on the chances of converting electronic communication into a face-to-face meeting. Methods ...
Accelerating Food and Drug Administration (FDA) product approval to market based on surrogate markers in the absence of proven efficacy creates a risk of adverse outcomes for affected patients, even ...